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Abstract Exocytosis of mast cell granules requires a vesicular-
and plasma membrane-associated fusion machinery. We exam-
ined the distribution of SNARE membrane fusion and Munc18
accessory proteins in lipid rafts of RBL mast cells. SNAREs
were found either excluded (syntaxin2), equally distributed
between raft and non-raft fractions (syntaxin4, VAMP-8,
VAMP-2), or selectively enriched in rafts (syntaxin3, SNAP-
23). Syntaxin4-binding Munc18-3 was absent, whereas small
amounts of the syntaxin3-interacting partner Munc18-2 consis-
tently distributed into rafts. Cognate SNARE complexes of
syntaxin3 with SNAP-23 and VAMP-8 were enriched in rafts,
whereas Munc18-2/syntaxin3 complexes were excluded. This
demonstrates a spatial separation between these two types of
complexes and suggests that Munc18-2 acts in a step di¡erent
from SNARE complex formation and fusion.
1 2003 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
Lipid rafts are specialized membrane microdomains with a
speci¢c composition of lipids and proteins that can be isolated
by their ability to £oat to low density after sucrose gradient
fractionation following lysis [1]. The selective enrichment of
components allows these microdomains to serve as platforms
for signal transduction [2,3] and intracellular tra⁄cking [4].
Abundant information exists on the involvement of lipid rafts
in signaling initiated by aggregation of the mast cell high
a⁄nity IgE receptor (FcORI) [5,6]. Aggregation recruits FcORI
into raft domains that contain a selective panel of molecules
such as Lyn, Fyn, LAT, Cbp/PAG etc. in order to achieve
e¡ective signaling and cellular responses [7^9]. One of the
physiological consequences is degranulation with release of
allergic in£ammatory mediators, a process that involves ex-
tensive membrane fusion [10,11]. Evidence in support of the
hypothesis that fusion can similarly rely on the enrichment of
proteins in rafts is rapidly accumulating [4]. Depletion of lip-
id-enriched cholesterol in rafts was shown to seriously perturb
secretory tra⁄cking in a variety of cell types [12^14].
SNAREs (soluble N-ethylmaleimide-sensitive fusion factor at-
tachment protein receptors), a large family of membrane fu-
sion proteins, were found to be present in lipid rafts. They
can be divided into vesicular or v-SNAREs and target or
t-SNAREs localized on opposing cellular compartments [15].
Fusion of these compartments is facilitated by their ability to
form stable macromolecular complexes [16]. The SNAREs Ti-
VAMP and syntaxin3 were shown to reside in lipid rafts at
the trans-Golgi level in MDCK cells, where they functioned in
apical sorting [17]. The neuronal SNAREs syntaxin1 and
SNAP-25 were also enriched in rafts, as revealed by their
association with detergent-resistant domains in PC12 cells
[18]. Although Lang et al. found that the same SNAREs are
solubilized by detergent, detailed £uorescence imaging of
these SNAREs in plasma membrane sheets demonstrated,
however, that they concentrate in cholesterol-dependent clus-
ters that de¢ne docking and fusion sites for exocytosis [19].
Several accessory proteins interact with SNAREs [15,20].
Among these is the sec1/Munc18 (SM) family of proteins.
Like SNAREs they are essential components of membrane
fusion as revealed by gene inactivation studies in several or-
ganisms [21]. Munc18 family members, in particular, are in-
volved in exocytosis of secretory vesicles with the plasma
membrane. In addition to the neuronal isoform Munc18-1,
two ubiquitously expressed mammalian isoforms, Munc18-2
and Munc18-3, with di¡erent syntaxin binding properties,
have been described. Munc18-2 binds to syntaxin1, 2 and 3,
while Munc18-3 binds to syntaxin2 and 4 [22,23]. Only
Munc18-1 has been studied for lipid raft localization and
was found to be excluded [18]. Their precise role in exocytosis
is still unknown and likely complicated, given that they can
also be considered inhibitors of exocytosis because they bind
to SNAREs of the syntaxin family and prevent them from
participating in SNARE complex formation [23,24].
In this study we compared the distribution of mast cell-ex-
pressed SNARE and Munc18 proteins [25^27] within and out-
side lipid rafts. Substantial heterogeneity in the distribution of
the individual proteins was observed. Examination of proteins
co-immunoprecipitating with syntaxin3 revealed that within
rafts syntaxin3 does not form a complex with Munc18-2,
whereas outside rafts these proteins are complexed.
2. Materials and methods
2.1. Antibodies and reagents
Antibodies directed against the following SNARE proteins were
produced in our laboratory and have been described: syntaxin2,
3 and 4, VAMP-8 [26]. The VAMP-2- and SNAP-23-speci¢c antibod-
ies were purchased from Synaptic Systems (Go«ttingen, Germany).
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Antibodies to Munc18-2 and Munc18-3 have been described [27].
Mouse IgE speci¢c for dinitrophenyl (DNP) [28] was used as ascites
£uid or was a⁄nity-puri¢ed. For some experiments the IgE was la-
belled with 125I as described [29]. FabP2 fragments of peroxidase-con-
jugated anti-rabbit and anti-mouse were purchased from Jackson Im-
munoResearch Laboratories (West Grove, PA, USA). DNP-HSA
(human serum albumin) was purchased from Sigma (St. Louis, MO,
USA).
2.2. Cell culture and cell stimulation
RBL-2H3 cells were maintained in Dulbecco’s modi¢ed Eagle’s
medium^glutamax (Invitrogen, France), supplemented with 10% fetal
calf serum, 100 IU/ml penicillin G and 100 Wg/ml streptomycin (In-
vitrogen), at 37‡C in a humidi¢ed 5% CO2 incubator. Forty-eight
hours before each experiment cells were plated at 3^4U106 cells in
15 cm culture dishes (Becton Dickinson) with complete medium and
sensitized overnight with 500 ng/ml anti-DNP IgE (or in the case of
ascites a 1:10 000 dilution). In some instances cells were sensitized
with [125I]IgE anti-DNP. Before stimulation, cells were washed and
resuspended in prewarmed activation bu¡er (PIPES 25 mM pH 7.2
containing 150 mM NaCl, 5 mM KCl, 1 mM MgCl2 and 0.5 mM
CaCl2). Cells were stimulated by aggregating receptor-bound IgE with
100 ng/ml DNP-HSA or were left unstimulated. The reaction was
stopped by adding an excess of ice-cold Tris^HCl 10 mM, pH 7.5,
containing 150 mM NaCl (TNV).
2.3. Preparation of lipid rafts and immunoprecipitations
Cells were solubilized in lysis bu¡er (TNV containing 0.1% (1.6
mM) Triton X-100, sodium orthovanadate 1 mM (Sigma), aprotinin
1000 U/ml (Sigma), pepstatin 10 Wg/ml, leupeptin 20 Wg/ml, amino-
ethyl benzenesulfonyl £uoride 2 WM (all Alexis, San Diego, CA,
USA)) by directly adding 1 ml of lysis bu¡er to adherent cells before
harvesting them by scraping as previously described [30]. The suspen-
sion was then transferred to a Dounce homogenizer and subjected to
15 strokes. The homogenate was centrifuged at 1000Ug for 10 min at
4‡C and the supernatant was mixed in an Ultra-clear TM centrifuge
tube (Beckman) with an equal volume of 85% sucrose. This mixture
was successively overlaid with 6 ml of 30% sucrose and 3.5 ml of 5%
sucrose, neither of which contained Triton X-100. The tubes were then
centrifuged at 200 000Ug at 4‡C, in a Beckman SW40Ti rotor for 16 h.
Sequential 1 ml fractions were harvested from the top of the gradient.
An opaque band at the interface between the 5% and 30% layers was
routinely harvested in fraction 4 and contained the lipid rafts.
125I-containing fractions were counted in a gamma counter, and ali-
quots were analyzed by the bicinchoninic acid method for total pro-
tein [31], and by immunoblotting for speci¢c proteins resolved by
electrophoresis on sodium dodecyl sulfate (SDS)^polyacrylamide gels.
For immunoprecipitation, Triton X-100 was added to individual
fractions to give a ¢nal concentration of 0.2%. Proteins were immu-
noprecipitated from pooled fractions using 5 Wg of indicated antibody
and protein A-Sepharose overnight. Immunoprecipitated proteins
were resolved by SDS^polyacrylamide gel electrophoresis (PAGE),
transferred to a nitrocellulose membrane and probed with the indi-
cated antibodies.
2.4. Immunoblotting
Proteins resolved by SDS^PAGE were transferred to nitrocellulose
membranes (Schleicher and Schuell, Dassel, Germany) and mem-
branes were blocked by incubation in Tris-bu¡ered saline containing
0.1% Tween 20 and 5% non-fat dry milk. Blots were then incubated
for 1 h at room temperature with primary antibodies. After several
washes, peroxidase-labelled anti-rabbit or anti-mouse IgGs were used
as secondary antibodies and incubated for 1 h at room temperature.
The blots were washed and developed using the enhanced chemolu-
minescence assay (Amersham Pharmacia Biotech).
2.5. Data analysis
All experimental data shown are representative of each series of
experiments and are from at least three independent experiments.
3. Results
Studies on the accumulation of SNARE proteins in lipid
raft fractions using sucrose gradient fractionation revealed
con£icting results [18,19]. Therefore, before investigating
whether SNARE proteins in mast cells are localized in lipid
rafts, we calibrated raft isolation according to a well estab-
lished procedure in RBL mast cells [5] by looking at the dis-
tribution of FcORI in these domains. Cultured RBL cells were
loaded with radioiodinated IgE anti-DNP as a measure for
FcORI, as its short-term binding (hours) is essentially irrevers-
ible due to its slow dissociation rate [29]. Cells were then
either left unstimulated or were stimulated by aggregating
cell surface-bound IgE with DNP-HSA for 6 min before sol-
ubilization in a low concentration of Triton X-100 and frac-
tionation through a discontinuous sucrose gradient. The dis-
tribution of FcORI in the 12 individual recovered fractions
was then evaluated by measuring the [125I]IgE counts. The
results in Fig. 1A show that surface FcORI in resting cells
was predominantly found in fractions 10^12 corresponding
to the high density non-lipid raft fractions. Only a minor
fraction of the receptor was associated with fractions 4^6,
which correspond to the low density lipid raft fraction. No
receptor was found in the very low density fractions 1^3.
However, a small amount was localized in intermediate frac-
tions 7^9. Following antigen-induced aggregation, the pres-
ence of FcORI in fractions 4^6 was increased by two-fold or
more as well as its presence in the intermediate fractions 7^9.
A corresponding decrease in fractions 10^12 was observed
indicating substantial recruitment into lipid rafts. This is in
agreement with previous studies [5,6]. We also investigated the
distribution of the adapter protein, LAT, and the cytoskele-
ton-associated protein, paxillin, in the pooled fractions using
immunoblot analysis. These proteins are well characterized
markers of lipid rafts and high density fractions, respectively
Fig. 1. Analysis of lipid raft distribution of the FcORI (A) and two
known marker proteins (B). [125I]IgE-loaded or IgE-loaded RBL
cells were either left unstimulated (3) or were stimulated (+) with
antigen (DNP-HSA) for 6 min before lysis under low detergent con-
ditions. Lysates were fractionated on a discontinuous sucrose gra-
dient to separate high and low density fractions. A: Twelve individ-
ual fractions were collected and analyzed for [125I]IgE counts.
B: Twelve individual fractions were collected and pooled by three
before immunoblot analysis using LAT- and paxillin-speci¢c anti-
bodies. Fractions 4^6 correspond to the low density lipid raft frac-
tions and fractions 10^12 correspond to the high density non-lipid
raft fractions.
FEBS 27563 13-8-03
I. Pombo et al./FEBS Letters 550 (2003) 144^148 145
[32]. As expected, paxillin did not distribute to the low density
fractions 4^6, but was found exclusively in the high density
non-lipid raft fractions 9^12 (Fig. 1B). In contrast, the dually
acylated LAT [9] was primarily found in the low density lipid
raft fraction and a slight increase of LAT in lipid rafts was
observed in stimulated cells, as previously described [32].
Having established the validity of our fractionation proce-
dure, we explored the raft distribution of SNARE proteins
expressed in RBL mast cells [25^27]. Fig. 2 shows an immu-
noblot analysis of proteins in pooled fractions from a sucrose
gradient separation, using speci¢c antibodies directed to v- and
t-SNARE proteins. Interestingly, marked di¡erences were
found. The t-SNARE syntaxin2 distributed almost exclusively
into the high density fraction, with only minimal amounts
present in the low density membrane domains. Syntaxin4
was found in higher proportion in the low density fractions
but some also was found in intermediate fractions. However,
a slight majority was found in the high density fractions. In
contrast, both syntaxin3 and SNAP-23 showed a selective
enrichment in low density lipid raft fractions. For v-SNAREs
an almost equal distribution was seen for VAMP-8 in all
fractions. In contrast, VAMP-2 showed some enrichment in
the intermediate density fractions. No signi¢cant change in
these patterns was noticed for any of the detected SNARE
proteins after FcORI stimulation. The SM proteins Munc18-2
and Munc18-3, which interact with syntaxin2/syntaxin3 or
syntaxin4, respectively, also showed a distinctive pattern.
While the majority of Munc18-2 distributed to the high den-
sity fraction we consistently saw a considerable amount of this
protein in the low density fraction (Fig. 2). In contrast,
Munc18-3 was not found in the low density fraction and dis-
tributed exclusively to the high density fractions. As for
SNAREs, Munc18 proteins showed no signi¢cant changes in
distribution following cell stimulation.
The di¡erential compartmentation of the various syntaxins
and Munc18 proteins on the membrane allowed us to tackle
the question of whether di¡erences might be observed in the
interaction of Munc18 with syntaxins. This might re£ect a
functional role as the fusion ability of syntaxins is inhibited
by its interaction with Munc18 proteins [33]. Thus, co-immu-
noprecipitation experiments were performed on fractions of
low detergent concentration lysates of resting and stimulated
RBL cells separated through a discontinuous sucrose gradient.
Syntaxin3 and syntaxin4 were immunoprecipitated from
pooled fractions and analyzed for associated proteins using
speci¢c antibodies. Fig. 3 shows that this method allowed
detection of macromolecular complexes of syntaxin4 with
SNAP-23 and VAMP-8. For the most part, the distribution
of syntaxin4 with co-immunoprecipitated VAMP-8 and
SNAP-23 largely resembled that seen in total extracts (Fig.
2). No enrichment of the syntaxin4-containing complexes
within or outside lipid rafts was observed regardless of
whether cells were resting or stimulated. Thus, evaluation of
any changes in its interaction with Munc18-3 within or out-
side lipid rafts did not merit investigation since Munc18-3 was
found exclusively in the high density fraction. In contrast,
because Munc 18-2 is found in low and high density fractions
we investigated its association with syntaxin3, which is also
found in both fractions. As depicted in Fig. 4, the recovery of
Fig. 2. Analysis of lipid raft distribution of SNARE and Munc18
proteins expressed in RBL mast cells. IgE-loaded RBL cells were
either left unstimulated (3) or were stimulated (+) with antigen
(DNP-HSA) for 6 min before lysis under low detergent conditions.
Lysates were fractionated on a discontinuous sucrose gradient to
separate high and low density fractions. Twelve individual fractions
were collected and pooled by three before immunoblot analysis us-
ing the indicated SNARE- and Munc18-speci¢c antibodies.
Fig. 3. Analysis of the lipid raft distribution of complexes of syntax-
in4 with SNARE proteins. IgE-loaded RBL cells were either left un-
stimulated (3) or were stimulated (+) with antigen (DNP-HSA) for
6 min before lysis under low detergent conditions. Lysates were
fractionated on a discontinuous sucrose gradient to separate high
and low density fractions. Twelve individual fractions were collected
and pooled by three. After addition of Triton X-100 to bring deter-
gent concentrations to 0.2%, pooled fractions were subjected to im-
munoprecipitation with syntaxin4-speci¢c antibody. Complexes with
SNAP-23 and VAMP-8 were examined by immunoblot analysis us-
ing speci¢c antibodies.
Fig. 4. Analysis of the lipid raft distribution of complexes of syntax-
in 3 with SNARE and Munc18 proteins. IgE-loaded RBL cells were
either left unstimulated (3) or were stimulated (+) with antigen
(DNP-HSA) for 6 min before lysis under low detergent conditions.
Lysates were fractionated on a discontinuous sucrose gradient to
separate high and low density fractions. Twelve individual fractions
were collected and pooled by three. After addition of Triton X-100
to bring detergent concentrations to 0.2%, pooled fractions were
subjected to immunoprecipitation with syntaxin3-speci¢c antibody.
Complexes with SNAP-23, VAMP-8 and Munc18 were examined by
immunoblot analysis using speci¢c antibodies.
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syntaxin3 in the immunoprecipitates showed a similar distri-
bution as in total extracts with a selective enrichment of this
protein in low density lipid raft fractions. Given that the dis-
tribution of SNAP-23 in total extracts was primarily in low
density fractions, it was not surprising that syntaxin3^SNAP
23 interactions were enriched in the low density fraction. In
contrast, given that VAMP-8 distributed equally between
fractions 4^12 in total extracts (Fig. 2), complexes of this
v-SNARE protein with syntaxin3 were selectively enriched
in lipid rafts. Strikingly a di¡erent pattern from that of total
lysates was seen in the case of Munc18-2, as all of the co-
immunoprecipitated protein was found in the high density
fractions despite the fact that they contained lower amounts
of syntaxin3. Thus, the Munc18-2 present in lipid raft do-
mains, as seen in total extracts, was not associated with syn-
taxin3. These results demonstrate a spatial separation of syn-
taxin3 SNARE complex formation from the site of Munc18-2
action in lipid rafts.
4. Discussion
There is substantial evidence that SNARE and SM proteins
are essential components in membrane fusion [21,34,35].
SNARE family proteins act by forming energetically favored
macromolecular complexes that diminish the energetic barrier
that blocks the merger of two lipid phases during fusion
[16,20,21]. The role of Munc18 proteins in membrane fusion
is not well understood because of the dichotomy of being
required for exocytosis and their ability to bind to syntaxins
and inhibit SNARE complex formation [23,24]. Nonetheless,
proposed models to explain this dichotomy invoke an inter-
action with a potential e¡ector, like a Rab or Munc13 protein,
to allow the transition from its function in sequestering syn-
taxins to its function in fusion [36^38].
To gain further insight into the interaction of SNARE and
Munc18 proteins in membrane fusion we examined their dis-
tribution in lipid raft domains. We con¢rmed the enrichment
of certain SNAREs, such as syntaxin3 and SNAP-23, in lipid
rafts [17], while others, such as syntaxin4, VAMP-2 and
VAMP-8, were more or less equally distributed between raft
and non-raft fractions. One of the examined SNAREs, syn-
taxin2, did not signi¢cantly localize to rafts but was found in
high density fractions. This heterogeneity of distribution in
membranes suggests functional di¡erences between individual
SNAREs expressed in mast cells that could relate to the re-
ported localization and function within di¡erent cellular com-
partments [25,26]. It could also be a result of the isolation
procedure, however, the consistent di¡erence in localization
observed between experiments, at a minimum, implies that
these proteins have properties that cause them to partition
di¡erently. Considerable heterogeneity of membrane compart-
ments has indeed been revealed by lysing the cells under dif-
ferent detergent condition [18] or by electron microscopic
studies of membrane sheets coupled to immunogold labeling
[39].
Concerning SM proteins, we found Munc18-3 to be com-
pletely excluded from lipid raft domains. This ¢nding is sim-
ilar to data obtained with the neuronal isoform Munc18-1
[18]. In contrast, although the majority of Munc18-2 was
found outside lipid raft domains a small but signi¢cant por-
tion reproducibly appeared in the lipid raft fractions. This
could indicate a speci¢c function for this small fraction of
Munc18-2 that may relate to its reported secretory granule
localization [27]. Despite its presence in rafts, complexes of
Munc18-2 with syntaxin3 were not found in low density frac-
tions demonstrating that they are spatially separated from the
sites of syntaxin3^SNARE complex formation that are highly
enriched in rafts. The loss of interaction of syntaxin3 with
Munc18-2 in lipid rafts is in agreement with previous evidence
for these sites as being preferential platforms for membrane
fusion [19] since this loss presumably renders syntaxin3 com-
petent for fusion. This is also supported by our observation of
the preferential interactions occurring between v-SNAREs
(like VAMP-8) and t-SNAREs (like syntaxin3) in these do-
mains. The lipid raft-independent binding of Munc18-2 with
syntaxin3 agrees with models suggesting that this interaction
precedes membrane fusion and that it may have a role beyond
maintaining the syntaxins in a fusion-incompetent state. In
fact, the additional role of a chaperone has been shown for
a yeast Munc18 homologue, which functions to regulate the
expression levels of its corresponding syntaxin partner [40].
This chaperone-like action was also seen in gene-inactivated
mice de¢cient for the neuronal Munc18-1 isoform as the cor-
responding syntaxin levels were decreased by approximately
70% [34]. Another possible role lies probably at the steps
involved in the docking of secretory granules. Indeed, ultra-
structural analysis of the distribution of large dense core
vesicles (LDCV) of chroma⁄n cells obtained from Munc18-
1-de¢cient mice has revealed an about 10-fold reduction in
morphologically docked LDCVs [41].
Because we consistently found a small amount of Munc18-2
in lipid raft domains, which was not complexed to syntaxin3,
other functional interactions and molecular partners are pos-
sible in these domains. This may now allow the means to
identify potential new partners because the lipid raft localiza-
tion holds promise of being a positive e¡ector for Munc18-2
action. Such identi¢cation would reconcile the data that re-
vealed a late action of Munc18-1 in fusion pore expansion [42]
with those that suggested an action in the steps preceding
fusion [7,34,41]. This would also promote the concept that
Munc18-2 has multiple roles in regulating fusion. Revealing
these roles is likely to signi¢cantly advance our knowledge of
vesicle fusion and exocytosis.
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